Wave Life Sciences SEC filings: 8-K

Filter: All · 8-K · 10-Q · 10-K · Form 4

8-KOct. 27, 2026, 7:35 a.m. ETView on SEC.gov
Results of operations and financial condition · Financial statements and exhibits
AI summary, unreviewedWave Life Sciences Q3 2026 EPS of -$0.30 beats -$0.32 consensus, but revenue of $13.2 million tops the $4.4 million estimate; cash $431.0 million, runway into 3Q 2028
8-KJuly 30, 2026, 7:38 a.m. ETView on SEC.gov
Results of operations and financial condition · Regulation FD disclosure · Financial statements and exhibits